Therapeutic Effect of Intranasal Insulin on Cognition, Function, and AD Biomarker

Project: Research project

Project Details


The goal of this trial is to examine the therapeutic effects of intranasally-­‐administered insulin (INI) on cognition, entorhinal cortex and hippocampal atrophy, and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment (aMCI) or mild Alzheimer’s disease (AD).
Effective start/end date3/1/134/30/16


  • University of California, San Diego (42756369///7RF1AG041845-02)
  • National Institute on Aging (42756369///7RF1AG041845-02)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.